Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
You might notice slight nausea, temporary redness at the injection site, or mild stomach discomfort
"Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial." NEJM, 2023;389:514526
Teams typically monitor for local injection-site reactions, short-term discomfort after administration, and changes that suggest the study schedule is producing a stronger or more persistent response than intended
rather, it supports the cellular environment required for healthy insulin function and metabolic efficiency
Why Skin Recipe
The ~380-hour half-life is the longest of any GLP-1 agonist in development
US$ 24.54
US$ 20.10
US$ 24.30
US$ 28.05
US$ 23.87
